Skin Rash Vanishes When Cancer Drug Targets Inflammation in Rare Syndrome Case
A Swiss case report shows that the JAK1/2 inhibitor ruxolitinib completely resolved steroid-refractory histiocytoid Sweet syndrome in a polycythemia vera ...
A Swiss case report shows that the JAK1/2 inhibitor ruxolitinib completely resolved steroid-refractory histiocytoid Sweet syndrome in a polycythemia vera ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine